All News
Continuously growing interest for AcouSort’s research systems
Over the past year, AcouSort has seen an increasing interest for the Company’s benchtop research systems. Most recently, AcouSort delivered and installed an AcouWash system at the Faculty of Medicine
Read MoreAcouSort to participate in the prestigious NIH Research Festival
AcouSort has been selected to participate in the yearly NIH Research Festival arranged by the prestigious American National Institute of Health (NIH). The event takes place September 18-22 and gathers
Read MoreAcouSort delivers AcouTrap system to Karolinska Institutet as part of the successful IndiCell project
In 2021, AcouSort AB received funding from Vinnova for the project IndiCell. The aim of the project is to enable the transfer of novel stem cell treatments from research to
Read MoreInterim Report Q2 2023
RegulatoryToday, AcouSort releases its interim report for Q2 2023. The report can be found in both Swedish and English here: AcouSort AB Q2 2023 SV AcouSort AB Q2 2023 ENG
Read MoreAcouSort invited to give a lecture at the Acoustofluidics conference
AcouSort’s Senior Scientist Mikael Evander has been asked to give an invited lecture at Acoustofluidics 2023, which celebrates its 20th anniversary this year. Acoustofluidics is a conference dedicated to exploring the science, the engineering,
Read MoreAcouSort wants to unleash the enormous potential of cell therapy
There is currently an incredible development of revolutionary cell and gene therapy treatments that will revolutionize healthcare through their ability to effectively treat and cure diseases that currently lack effective
Read MoreCell therapy collaboration with leading global life science company continues to expand
RegulatoryIn January 2023, AcouSort reported that the company’s collaboration with a global life science company active within the cell therapy field had been extended with a second phase. The second
Read MoreAcouSort strengthens its R&D capabilities by the recruitment of Henrik Johansson
AcouSort has recruited Henrik Johansson to the position as Director of Research and Technology. Henrik has significant experience from startup environment within the biotech space as well as from R&D
Read MoreAcouSort continues its strategic collaboration with academia – delivers a unique AcouWash 2 system to Lund University
In the autumn of 2022, AcouSort received an order from Lund University for the development of a modified AcouWash 2 system, custom-designed to support the separation of circulating tumor cells
Read MoreInterim Report Q1 2023
RegulatoryToday, AcouSort releases its interim report for Q1 2023. The report can be found in both Swedish and English here: AcouSort AB Q1 2023 SV AcouSort AB Q1 2023 ENG
Read More